Growth Metrics

Aptevo Therapeutics (APVO) Interest Expenses (2017 - 2018)

Aptevo Therapeutics (APVO) has disclosed Interest Expenses for 2 consecutive years, with $474000.0 as the latest value for Q3 2018.